innoscripta SE, a provider of a scalable software platform for managing research and development (R&D) activities, announced a robust financial performance for the first half of 2026, with revenue increasing by 43% year-on-year to EUR 63.1 million. The company's adjusted EBIT rose by 49% to EUR 36.4 million, reflecting an adjusted EBIT margin of 57.7%. These figures underscore the continued success of the company's strategic initiatives and operational efficiency.
The German R&D tax allowance (Forschungszulage) remains a key growth driver, contributing to a customer base that has expanded to over 2,900 companies. This growth is supported by Clusterix, innoscripta's platform that centralizes project structuring, data management, and application submissions. The platform's enhanced capabilities in automated data validation and standardized workflows have improved data quality and efficiency, providing a solid foundation for international scaling.
International expansion has progressed as planned, with successful market entries into France, the UK, and the US. The company opened its first office near Toulouse, France, and has already secured customers there. In the UK, innoscripta established a presence in Manchester as of July 1, 2026, and has begun serving its first clients in the US. Clusterix's flexibility in adapting to different regulatory requirements has been instrumental in facilitating these new market entries efficiently.
The company also opened an office in Hamburg, Germany, as part of its regional expansion strategy. These moves are aligned with the company's goal to leverage its technology across diverse markets and regulatory environments, enhancing its competitive position in the global R&D tax incentive landscape.
Given the strong first-half performance and the positive trajectory, the Management Board of innoscripta has confirmed its guidance for the full year 2026. The company expects Group revenue of at least EUR 140 million and EBIT of at least EUR 80 million, assuming consistent timing of the submission and approval of customers' applications. This guidance reflects confidence in the sustained demand for R&D tax incentive services and the scalability of the Clusterix platform.
Detailed financial figures for the first half of 2026 are available in the Half-Year Report on the Company's website in the Investors section. Additionally, innoscripta hosted a virtual earnings call on its H1 2026 results, with the invitation and dial-in link available on the Company's website under Investor Events.
innoscripta SE's strong results and strategic expansion highlight its position as a key player in the R&D management software sector, offering companies a way to efficiently manage innovation projects and optimize their R&D tax incentives. As the company continues to grow its international footprint, it is well-positioned to capitalize on the increasing complexity of R&D regulations worldwide.
